CG Oncology vs Rubius Therapeutics

CG Oncology logo

CG Oncology

Attacking Bladder Cancer for a Better Tomorrow

121 employees · est. 2010 · Irvine, United States

VS
Rubius Therapeutics logo

Rubius Therapeutics

Red blood cells are no longer just for carrying oxygen. At Rubius Therapeutics, we are transforming them into medicines

18 employees · est. 2014 · Cambridge, United States

CG Oncology is the older company (2010 vs 2014); CG Oncology is the larger of the two.

Side-by-Side Comparison

CG Oncology Rubius Therapeutics
Founded
2010 older 2014
Headquarters
Irvine, United States Cambridge, United States
Employees
121 larger 18
Industry
Biotechnology, Health Care Biotechnology
Funding Stage
Series F IPO
Total Funding
$317.57M $686.00M
Funding Rounds
7 6
Services
Not tracked yet real money casino gaming, casino reviews and comparisons, bonus offers and promotions, secure payment processing, VIP club management
Target Customers
Not tracked yet Australian casino players, jackpot seekers, mobile casino users, crypto gamblers
Taxonomy
Oncolytic ImmunotherapyBladder CancerClinical-Stage BiopharmaceuticalCG0070ImmunotherapiesBioSante Pharmaceuticals +9 Biopharmaceutical CompanyCellular MedicinesGenetic EngineeringRed Cell TherapeuticsOncologyAutoimmune Diseases +9
Website
cgoncology.com rubiustx.com
CG Oncology logo

About CG Oncology

CG Oncology is a late-stage clinical biopharmaceutical company, founded in 2010, focusing on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is in a Phase 3 trial for the t...

Rubius Therapeutics logo

About Rubius Therapeutics

Rubius Therapeutics, founded in 2014 and headquartered in the United States, is at the forefront of biotechnology by innovatively repurposing red blood cells as medicines. With their slogan, "Red blood cells are no longer just for carrying oxygen. At Rubius Therapeutics, we are transforming them int...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches CG Oncology and Rubius Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when CG Oncology or Rubius Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

CG Oncology was founded in 2010, based in Irvine, United States, with 121 employees. CG Oncology is a late-stage clinical biopharmaceutical company, founded in 2010, focusing on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder c. Rubius Therapeutics was founded in 2014, based in Cambridge, United States, with 18 employees. Rubius Therapeutics, founded in 2014 and headquartered in the United States, is at the forefront of biotechnology by innovatively repurposing red blood cells as medicines. With their slogan, "Red bloo.
CG Oncology has raised $317.57M and Rubius Therapeutics $686.00M. Latest stage: CG Oncology Series F, Rubius Therapeutics IPO.
Both work in Biotechnology and list biopharmaceutical company among their focus areas.

Compare CG Oncology with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CG Oncology on 11 Sep 2024, and Rubius Therapeutics on 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes